Ontario Cancer Research Ethics Board
MaRS Centre, Suite 510 | 661 University Avenue
Toronto, Ontario | Canada M5G 0A3
416-673-6649 or 1-866-678-6427 ext. 6649 | www.ocreb.ca
Monthly Teleconference Summary
April 17, 2015 @ 9am
ATTENDEES
1.
2.
3.
4.
Sites:
Hamilton Health Sciences (JCC)
Lakeridge Health (Oshawa)
Lawson (London) - LRCP
The Ottawa Hospital
 Cancer Centre
 OHRI
5. St. Joseph’s Healthcare (Hamilton)
6. Southlake Regional Health Centre
OCREB:
Aurora de Borja, Janet Manzo, Safia Moosvi, Cindy Sandel, Alison van Nie, Kathie Zeman
REGRETS
11.
12.
13.
14.
Sites:
15.
16.
17.
18.
OCREB:
7. Sunnybrook Health Sciences Centre
 Odette Cancer Centre
 SRI
8. Toronto East General
9. Trillium Health Partners - Credit Valley Hospital
10. UHN - Princess Margaret Cancer Centre
 Clinical Trial Support Unit
 Drug Development Program
Cambridge Memorial
Grand River Hospital
Health Sciences North (Sudbury)
Humber River Hospital
Kingston General Hospital
Mount Sinai Hospital
Niagara Health System
North York General Hospital
19.
20.
21.
22.
23.
24.
25.
26.
Royal Victoria Regional Health Centre
St. Joseph’s Health Centre (Toronto)
St. Michael’s Hospital
Thunder Bay Regional Health Sciences Centre
Trillium Health Partners - Mississauga Hospital
William Osler Health Centre
Windsor Regional Hospital
Women’s College Hospital
Richard Sugarman (Chair), Mark Whissell (VC), Yooj Ko (VC)
If you temporarily have to leave the teleconference, please hang up and dial in again when you are able to rejoin. Putting your phone on hold causes interference with all of the other lines.
If you no longer wish to receive the monthly teleconference agendas and minutes, please contact Alison van Nie
at alison.vannie@oicr.on.ca to be removed from the OCREB distribution list. NOTE. You will no longer receive
communication from OCREB, with the exception of relevant business communication, as applicable. You may
request to be reinstated in the distribution list at any time.
NOTEWORTHY ITEMS
A place for sharing new information, updates and other noteworthy items affecting the research community…
Regulatory/Guidance Updates:
1. Use of Electronic Informed Consent (eIC) in Clinical Investigations Questions and Answers Guidance for
Industry DRAFT GUIDANCE March 9, 2015 – the consultation is open for 60 day Draft Guidance
2. Apple announces that its medical research app-builder, ResearchKit, has a module for building
electronic consent forms. The five apps/studies that hit the App store after Apple’s announcement all
utilized remote, electronic informed consent processes that hinted at the potential for wider use.
OCREB is qualified under the Clinical Trials Ontario REB Qualification Program

Mount Sinai’s Icahn School of Medicine worked with LifeMap Solutions to create Asthma Health,
which is studying patterns of asthma symptoms. Among other plans, the study aims to match up a
participant’s report of symptom severity with the air quality at that location at that moment.

Massachusetts General Hospital has designed GlucoSuccess to help manage diabetes symptoms
and study how personal habits affect glucose levels.

Stanford has MyHeart Counts, which track how personal habits affect cardiovascular health.
MyHeart Counts monitors daily activities, tracks behavior through surveys, and correlates that data
with reported cardiovascular health.

Sage Bionetworks and the University of Rochester are studying Parkinson ’s disease with mPower.
This study uses the iPhone’s accelerometer and touch screen to assess participants’ balance and
dexterity.

In collaboration with the Dan-Farber Cancer Institute, Penn Medicine, and UCLA’s Jonsson
Comprehensive Cancer Center, Sage Bionetworks also has created Share the Journey, a program
to track the daily impact of breast cancer.
3. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research
Involving Human 2013 – nicely laid out and searchable
http://jama.jamanetwork.com/article.aspx?articleid=1760318&utm_source=fbpage&utm_medium=social
_jn&utm_term=164687182&utm_content=content_engagement%7Carticle_engagement&utm_campaign
=article_alert&linkid=13323096#.VR9jbvcFzk0.linkedin
4. GCP-related, Access to Investigational Products: Draft Guidance- Individual Patient Expanded
Access Applications
For access outside of a clinical trial, by patients with serious or life-threatening diseases or conditions for
which there are no comparable alternative treatments.
https://www.federalregister.gov/articles/2015/02/10/2015-02561/individual-patient-expanded-accessapplications-form-fda-3926-draft-guidance-for-industry
5. WHO Calls for Increased Transparency in Medical Research 14 APRIL | 2015
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical
products, whatever the result.
The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and
medical devices for use by populations are supported by the best available evidence.
http://www.who.int/mediacentre/news/notes/2015/medical-research-transparency/en
NEWSWORTHY
1. http://www.buzzfeed.com/azeenghorayshi/johns-hopkins-sued-for-1-billion-over-unethical-stdstudy#.jsaOeQOnP
Guatemalans sue over research in 1940s
2. Ebola Vaccines Will Enter Phase III Soon - Two Ebola vaccines are set to enter Phase III testing in West
Africa soon Read More
A trial in Guinea or Sierra Leone would aim to enroll 27,000 patients. Patients will be randomized to
receive either a chimp adenovirus-carried vaccine developed by the NIAID and GlaxoSmithKline, or
another developed by the Public Health Agency of Canada and licensed to NewLink Genetics and
Merck.
3. N2 News:
 N2/CAREB REB SOPs – French language version
https://oicronca.box.com/s/95k7ydj574579ajvbe06
Teleconference 2015-Apr-17
Page 2 of 18

N2 – release of tools/information sheets related to HC inspections
https://oicronca.box.com/s/reo8vwr0zzk0pkpqjujxbfr3xit18qr8

The much anticipated GCP refresher course is now released.
CANADA_GCP_Refre Sign In CITI Generic
sher_Course_AnnouncementClean
2015-03-17.pdf
April 2015.pdf
NOTICES
Revised Consent Form Templates
The current OCREB/NCIC Main ICF template has revised and the new version of the form will be posted in the
next week or two (once formatting, etc., has been completed). The current OCREB ICF template also will be
revised, to reflect these changes, and the new version will be posted shortly. The two documents are very
similar with minor additions to the OCREB ICF to reflect specific information that has been negotiated with
OCREB’s affiliated centres. The documents have not changed significantly, although the risk section has been
updated to allow for options when describing the risks and there have been minor changes in wording and
organization in some sections of the document.
Change to Optional Consent Signature Page
The optional ICF templates have been updated due to a concern/audit finding related to the date format on the
signature pages and inconsistencies with the data entered. To address this finding the date formats (under the
signature lines) were removed – no other changes have been made, however, the version date was updated.
NRG
RTOG/NRG has new data collection forms that may not be applicable for the studies conducted in Ontario.
Please note that some of the information in the forms may not apply to studies conducted under OCREB –
please review the approval letter to ensure that only those forms that are approved for use with the study are
implemented.
Brochures/Advertisements
There have been increased submissions of brochures and advertisements for studies – please remember that
these are considered to be participant materials which must be approved prior to implementation.
Mandatory use of Templates
Please note that OCREB now requires that ICFs submitted to the Board for review must use the OCREB
template(s). Initial submissions that include ICFs that are not consistent with the OCREB templates may be
returned to the applicant.
Submission of ‘urgent’ amendment
Please remember – to prevent a delay in the review and approval of urgent information - if there is an
urgent amendment that requires immediate review, and an amendment already has been submitted and is under
review, the applicant should contact the REC so that the previous amendment may be withdrawn or information
contained in the new amendment can be added.
REMINDERS
Sponsor Access
Please consider granting the sponsor or CRO access to their studies in O2. They need the REB information
anyway, so it might save them asking the sites for the information. In order to grant them access, they must have
an O2 account. If they do not have one, send their detailed contact information to O2 Support and request an
account. Once they have an O2 account, use the “Edit Guest List” activity and select their name/names from a
drop-down list to grant them view access. Please also consider adding a willing sponsor or CRO contact to
Teleconference 2015-Apr-17
Page 3 of 18
Section 1.5 of the provincial application form (check with them first). They can be added to the application
whenever it is open to the Provincial Applicant for editing, or at any time by using the “Edit Study Personnel”
activity. This will allow the Provincial Applicant - using the “Send for Sponsor Review” activity - to send/route
ANY provincial application to the sponsor/CRO contact listed in Section 1.5 for completion. The sponsor/CRO
contact can complete the entire application including uploading any documents and use the “Submit Sponsor
Review” activity to send the application back to the Provincial Applicant to review and submit.
Submission of identifiers
Please remember to de-identify all documents prior to submission (e.g. protocol deviations, AEs). The only
study-related identifier that can be included is the study participant ID (i.e., redact all other identifiers including
initials).
CCO Funding - No updates.
Billing Information
Please obtain the correct billing information to enter into section 1.2a of the provincial application form, and
update the information when applicable by editing the sponsor billing information. Billing information applies to
any Industry sponsored studies submitted on or since April 2013 (starting with 13-024 but including 13-020). The
contact information in this section automatically populates the invoices used to collect the review fees (for initial
and annual reviews). Please ensure that the sponsor/CRO rep understands what this information is collected
and used for and confirm that it is the correct billing information for Canadian sites. This is particularly important
for CROs working out of the US. We have seen the CRO contact information entered into this section instead of
the billing information, creating additional work and delays.
OCREB MEMBERSHIP CHANGES
The OCREB membership roster was last updated on April 1, 2015. However, an April 27, 2015 version will be
posted after April 27. The current and archived membership lists can be accessed from O2 Home
(https://ocrebonline.ca) under “Member Lists”.
PROJECT SUBMISSION SUMMARY LIST
The list of studies with OCREB (project submission summary spreadsheet) is available on the O2 Home page
https://ocrebonline.ca. The current version posted is March 27, 2015.
OCREB ONLINE (O2)
Key Recent Enhancements
See also the “What’s New” section of O2 Home - https://ocrebonline.ca
Between March 13 and 15, a major upgrade was applied to the O2 system. Although it was relatively seamless
for the end users, it involved a lot of testing and coordination behind the scenes. Thanks to Terry Liu, Safia
Moosvi, the OICR IT team and the RECs for their time and effort resulting in a smooth transition.
Note that Internet Explorer 11 (IE11) is now supported. See O2 Home for the list of supported browsers.
Outstanding issues (logged but not yet resolved):



For amendments involving a change in PI, the new PI is not able to see the study in the action items even
before they accept the study. This fix will be made in a future patch.
Guidance text feature for application forms and workspaces;
Archiving for 25 years so system can be used as ethics study files.
Teleconference 2015-Apr-17
Page 4 of 18
STUDY SUBMISSION STATUS
For a list of all active studies with OCREB, see the Project Submission spreadsheet at https://ocrebonline.ca
New studies submitted for the April meeting:
15-026
Cindy
NRG
NRG-LU001
Tsakiridis, Theo
HHS
Yvonne Kinrade
15-027
Kathie
Polynoma
103A-301
Butler, Marcus
UHN
Andreea Sederias
15-028
Aurora
PMHC
MOBILITY-002
Bedard, Philipe
UHN
Bonnie Kwan
15-029
Cindy
Pfizer
B1371012
Wells, Richard
SHSC
Arlene Mete
15-030
Aurora
PMHC
OZM-061
Oza, Amit
UHN
Bonnie Kwan
15-031
Kathie
AZ
D0816C00009
Oza, Amit
UHN
Bonnie Kwan
15-032
Aurora
Momenta
MOM-M402-103
Moore, Malcolm
UHN
Anna Dodd
15-033
Cindy
Merck
MK-3475-061
Vincent, Mark
LHSC
Mary Beth Husson
Studies in Pre Submission:
Exelixis
XL184–401
Krzyzanowska, Monika
UHN
Amirah Shahin
INCB 18424-267
Chen, Eric
UHN
Bonnie Kwan
56021927PCP3001
Winquist, Eric
LHSC
Mary Beth Husson
NCIC
IND.221
Hirte, Hal
HHS
Yvonne Kinrade
Tokai
TOK-200-15
Emmenegger, Urban
Bayer
BAY 1000394 / 17616
Hirte, Hal
Incyte
Janssen
SHSC
HHS
Jennifer Woo
Yvonne Kinrade
Other
 NCIC CTG SRC.7/Alliance 0911005: A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of
Sorafenib in Desmoid Tumors or Agressive Fibromatosis (DT/DF). March 20 NCIC email notice.
CONTINUING REVIEW APPLICATIONS DUE FOR THE MAY MEETING – see
next section
Be sure to keep track of the expiry dates of your studies. The system sends courtesy reminders 49 days, 15
days and 1 day prior to the expiry date.
There are approximately 45 studies involving 130 centre applications (approximately 175 continuing review
applications) due by the April 23rd deadline for the May 8th, 2015 OCREB Meeting, (i.e., expiring May 8th to
June 11h 2015, inclusive), unless a study closure has been or will be submitted.
Next OCREB teleconference: June 5, 2015 at 9 am
The May meeting is cancelled since most of the OCREB team will be away at the CAREB national conference.
Teleconference 2015-Apr-17
Page 5 of 18
CONTINUING REVIEW APPLICATIONS DUE FOR THE MAY 8th MEETING
Study ID
PI
Centre
Centre
Contact
Application
Type
Expiry Date
B-42
Elser (MSH),
Christine
Mount Sinai
Hospital
Olivera
Jugovic
Provincial
09-May-15
07-040
Sponsor
National Surgical
Adjuvant Breast and
Bowel Project(NSABP)
National Surgical
Adjuvant Breast and
Bowel Project(NSABP)
B-42
Elser (MSH),
Christine
Olivera
Jugovic
Centre
09-May-15
Cindy
Sandel
07-041
Amgen Canada Inc.
20060342
Oza, Amit M.
Riddhi Gehi
Provincial
09-May-15
Cindy
Sandel
07-041
Amgen Canada Inc.
20060342
Oza, Amit M.
Mount Sinai
Hospital
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Katie Allen
Centre
09-May-15
Cindy
Sandel
08-018
Hoffmann-La Roche
Limited (Canada)
BO20906 BETH
Hamm, Caroline
Windsor Regional
Hospital
Donna
Clinansmith
Provincial
09-May-15
Cindy
Sandel
08-018
Hoffmann-La Roche
Limited (Canada)
BO20906 BETH
Hamm, Caroline
Patricia
Dupuis
Centre
09-May-15
Cindy
Sandel
08-018
BO20906 BETH
Elser (UHN),
Christine
Tazmin
Usmani
Centre
09-May-15
Cindy
Sandel
08-023
26866138LYM-3002
Crump, Michael
Nimisha Dave
Provincial
12-May-15
Cindy
Sandel
08-023
Hoffmann-La Roche
Limited (Canada)
Johnson & Johnson Janssen-Ortho (change
to Janssen)
Johnson & Johnson Janssen-Ortho (change
to Janssen)
26866138LYM-3002
Crump, Michael
Nimisha Dave
Centre
12-May-15
Cindy
Sandel
08-031
NCIC Clinical Trials
Group (NCIC CTG)
PRC.3
Zlotta (UHN),
Alexandre R.
Grace Garcia
Provincial
09-May-15
Cindy
Sandel
08-031
NCIC Clinical Trials Group
(NCIC CTG)
PRC.3
Zlotta (UHN),
Alexandre R.
Windsor Regional
Hospital
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Grace Garcia
Centre
09-May-15
Cindy
Sandel
08-031
NCIC Clinical Trials Group
(NCIC CTG)
PRC.3
Zlotta (MSH),
Alexandre R.
Grace Garcia
Centre
09-May-15
Cindy
Sandel
09-026
Janssen Research &
Development
COU-AA-302
Mukherjee, Som
Yvonne
Kinrade
Provincial
09-May-15
REC
OCREB #
Cindy
Sandel
07-040
Cindy
Sandel
Teleconference 2015-Apr-17
Mount Sinai
Hospital
Lawson Health
Research
Institute(London)
Page 6 of 18
Centre
Contact
Application
Type
Expiry Date
Yvonne
Kinrade
Centre
09-May-15
Mary Beth
Husson
Centre
09-May-15
Katharine
Devitt
Provincial
09-May-15
Katharine
Devitt
Centre
09-May-15
Sunnybrook Health
Sciences Centre
Natalie
Coburn
Centre
09-May-15
Hamilton Health
Sciences
Yvonne
Kinrade
Provincial
09-May-15
Hamilton Health
Sciences
UHN-Princess
Margaret Cancer
Centre
Lawson Health
Research
Institute(London)
Trillium Health
Partners - Credit
Valley Hospital
Yvonne
Kinrade
Centre
09-May-15
Riddhi Gehi
Provincial
09-May-15
Mary Beth
Husson
Centre
09-May-15
Sandy Phillips
Centre
09-May-15
REC
OCREB #
Sponsor
Study ID
PI
Cindy
Sandel
09-026
Janssen Research &
Development
COU-AA-302
Mukherjee, Som
Cindy
Sandel
09-026
Janssen Research &
Development
COU-AA-302
Winquist, Eric W.
Aurora de
Borja
09-028
UHN-Princess Margaret
Cancer Centre
quality
improvement
Wei, Alice C.C.
Aurora de
Borja
09-028
UHN-Princess Margaret
Cancer Centre
quality
improvement
Wei, Alice C.C.
Hamilton Health
Sciences
Lawson Health
Research
Institute(London)
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Aurora de
Borja
09-028
UHN-Princess Margaret
Cancer Centre
quality
improvement
Coburn, Natalie
Cindy
Sandel
09-031
Radiation Therapy
Oncology Group (RTOG)
RTOG 0534
Lukka, Himanshu
R.
Cindy
Sandel
09-031
RTOG 0534
Lukka, Himanshu R.
Cindy
Sandel
09-032
PHL-072
Knox, Jennifer J.
Cindy
Sandel
09-032
PHL-072
Welch, Stephen
Cindy
Sandel
09-032
PHL-072
Strevel, Elizabeth
Cindy
Sandel
09-032
PHL-072
Hirte, Holger (Hal)
W.
Cindy
Sandel
09-032
Radiation Therapy
Oncology Group (RTOG)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
PHL-072
Cindy
Sandel
10-034
NCIC Clinical Trials
Group (NCIC CTG)
Cindy
Sandel
10-034
NCIC Clinical Trials Group
(NCIC CTG)
Teleconference 2015-Apr-17
Centre
Yvonne
Kinrade
Centre
09-May-15
Knox, Jennifer J.
Hamilton Health
Sciences
UHN-Princess
Margaret Cancer
Centre
Smitha
Udagani
Centre
09-May-15
IND.202
Petrella, Teresa
Marie
Sunnybrook Health
Sciences Centre
Carolyn Lim
Provincial
09-May-15
IND.202
Song, Xinni
The Ottawa
Hospital
Lisa Turriff
Centre
09-May-15
Page 7 of 18
Centre
Contact
Application
Type
Expiry Date
Carolyn Lim
Centre
09-May-15
Mary Beth
Husson
Centre
09-May-15
Hamilton Health
Sciences
Yvonne
Kinrade
Centre
09-May-15
Verma, Shailendra
The Ottawa
Hospital
Amy
Henderson
Provincial
09-May-15
20060359 (DCare)
Sehdev, Sandeep R.
William Osler
Health Centre
Johnson
Dartey
Centre
09-May-15
Amgen Canada Inc.
20060359 (DCare)
Mates, Mihaela
Kingston General
Hospital
Carrie Lindsay
Centre
09-May-15
10-035
Amgen Canada Inc.
20060359 (DCare)
Bin, James
Christine
Stewart
Centre
09-May-15
10-035
Amgen Canada Inc.
Centre
09-May-15
10-035
Amgen Canada Inc.
20060359 (DCare)
20060359 (DCare)
Centre
09-May-15
10-035
Amgen Canada Inc.
20060359 (DCare)
Califaretti, Nadia B.
10-039
NCIC Clinical Trials
Group (NCIC CTG)
10-039
NCIC Clinical Trials Group
(NCIC CTG)
10-039
NCIC Clinical Trials Group
(NCIC CTG)
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
REC
OCREB #
Sponsor
Study ID
PI
Centre
Cindy
Sandel
10-034
NCIC Clinical Trials Group
(NCIC CTG)
IND.202
Petrella, Teresa
Marie
Cindy
Sandel
10-034
NCIC Clinical Trials Group
(NCIC CTG)
IND.202
Ernst, Scott
Sunnybrook Health
Sciences Centre
Lawson Health
Research
Institute(London)
Cindy
Sandel
10-034
NCIC Clinical Trials Group
(NCIC CTG)
IND.202
McWhirter, Elaine
Aurora de
Borja
10-035
Amgen Canada Inc.
20060359 (DCARE)
Aurora de
Borja
10-035
Amgen Canada Inc.
Aurora de
Borja
10-035
Aurora de
Borja
Aurora de
Borja
Aurora de
Borja
Aurora de
Borja
Aurora de
Borja
Aurora de
Borja
Aurora de
Borja
Teleconference 2015-Apr-17
El-Maraghi, Robert
Verma, Shailendra
Toronto East
General Hospital
Royal Victoria
Regional Health
Centre
The Ottawa
Hospital
Christine Di
Marco
Amy
Henderson
Carol
Ballantyne
Centre
09-May-15
MA.32
Goodwin (UHN),
Pamela
Grand River
Hospital
UHN-Princess
Margaret Cancer
Centre
Anna Malik
Provincial
09-May-15
MA.32
Goodwin (MSH),
Pamela
Mount Sinai
Hospital
Olivera
Jugovic
Centre
09-May-15
Rahim, Yasmin
Southlake Regional
Health Centre
Priyanka
Khandelwal
Centre
09-May-15
MA.32
Hamm, Caroline
Windsor Regional
Hospital
Jane Coulter
Centre
09-May-15
MA.32
Segal, Roanne J.
The Ottawa
Hospital
Lisa Turriff
Centre
09-May-15
MA.32
Page 8 of 18
REC
OCREB #
Sponsor
Study ID
PI
Centre
Centre
Contact
Application
Type
Expiry Date
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Bahl, Mala
Grand River
Hospital
Carol
Ballantyne
Centre
09-May-15
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Freedman , Orit
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
Aurora de
Borja
10-039
Aurora de
Borja
Edeliza
Mendoza
Centre
09-May-15
Goodwin (UHN),
Pamela
Lakeridge Health
UHN-Princess
Margaret Cancer
Centre
Anna Malik
Centre
09-May-15
MA.32
Mukherjee, Som
Hamilton Health
Sciences
Yvonne
Kinrade
Centre
09-May-15
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Mates, Mihaela
Carrie Lindsay
Centre
09-May-15
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Vandenberg,
Theodore A.
Mary Beth
Husson
Centre
09-May-15
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Myers, Robert E.
Helena Wong
Centre
09-May-15
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Haq, Rashida
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
Aurora de
Borja
10-039
Aurora de
Borja
Kingston General
Hospital
Lawson Health
Research
Institute(London)
Trillium Health
Partners - Credit
Valley Hospital
Aziz Jiwajee
Centre
09-May-15
Dueck, Dorie-Anna
C.
St. Michael's
Hospital
Thunder Bay
Regional Health
Sciences Centre
Carol Pelletier
Centre
09-May-15
MA.32
Pritchard, Kathleen
I.
Sunnybrook Health
Sciences Centre
Carolyn Lim
Centre
09-May-15
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Findlay, Brian
Peter
Linda Illes
Centre
09-May-15
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Gapski, John A.P.
Niagara Health
System
Trillium Health
Partners Mississauga
Hospital
Kathryn
Zurawel
Centre
09-May-15
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Bin, James
Toronto East
General Hospital
Christine
Stewart
Centre
09-May-15
Aurora de
Borja
10-039
NCIC Clinical Trials Group
(NCIC CTG)
MA.32
Chouinard, Edmond
E.
Cambridge
Memorial Hospital
Stephanie
Evans
Centre
09-May-15
Teleconference 2015-Apr-17
Page 9 of 18
REC
OCREB #
Sponsor
Study ID
PI
Centre
Centre
Contact
Application
Type
Expiry Date
Cindy
Sandel
10-040
Hoffmann-La Roche
Limited (Canada)
BO22589
Glenns, Vivian P.
North York General
Hospital
Anne
Abraham
Provincial
09-May-15
Cindy
Sandel
10-040
Hoffmann-La Roche
Limited (Canada)
BO22589
Glenns, Vivian P.
North York General
Hospital
Anne
Abraham
Centre
09-May-15
Kathie
Zeman
10-043
Radiation Therapy
Oncology Group (RTOG)
RTOG 0848
Pantarotto, Jason
The Ottawa
Hospital
Amy
Henderson
Provincial
09-May-15
Kathie
Zeman
10-043
Radiation Therapy
Oncology Group (RTOG)
RTOG 0848
Pantarotto, Jason
Amy
Henderson
Centre
09-May-15
Kathie
Zeman
10-043
Radiation Therapy
Oncology Group (RTOG)
RTOG 0848
Fisher, Barbara J.
Mary Beth
Husson
Centre
09-May-15
Cindy
Sandel
10-044
PMH Drug Development
Program (PMHDDP)
PMH DDP
CRCLM1
MacKay, Helen J.
The Ottawa
Hospital
Lawson Health
Research
Institute(London)
UHN-Princess
Margaret Cancer
Centre
Smitha
Udagani
Provincial
09-May-15
Cindy
Sandel
10-044
PMH Drug Development
Program (PMHDDP)
PMH DDP
CRCLM1
Burkes, Ronald
Louis
Mount Sinai
Hospital
Janet Smith
Centre
09-May-15
Cindy
Sandel
10-044
PMH Drug Development
Program (PMHDDP)
PMH DDP
CRCLM1.
Ko, Yoo-Joung
(Yooj)
Adam Lam
Centre
09-May-15
Cindy
Sandel
10-044
PMH Drug Development
Program (PMHDDP)
PMH DDP
CRCLM1.
MacKay, Helen J.
Sunnybrook Health
Sciences Centre
UHN-Princess
Margaret Cancer
Centre
Silvi Kuld
Centre
09-May-15
Cindy
Sandel
10-044
PMH Drug Development
Program (PMHDDP)
PMH DDP
CRCLM1.
Asmis, Tim
Amy
Henderson
Centre
09-May-15
Cindy
Sandel
10-044
PMH Drug Development
Program (PMHDDP)
PMH DDP
CRCLM1.
Welch, Stephen
Mary Beth
Husson
Centre
09-May-15
Kathie
Zeman
10-050
UHN-Princess Margaret
Cancer Centre
CAMN107YCA
03T
Schuh, Andre
Alexis
Vaughan
Provincial
20-May-15
Kathie
Zeman
10-050
UHN-Princess Margaret
Cancer Centre
CAMN107YCA
03T
Schuh, Andre
Alexis
Vaughan
Centre
20-May-15
Aurora de
Borja
10-053
NCIC Clinical Trials
Group (NCIC CTG)
IND.198
Welch, Stephen
Mary Beth
Husson
Provincial
14-May-15
Teleconference 2015-Apr-17
The Ottawa
Hospital
Lawson Health
Research
Institute(London)
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Lawson Health
Research
Institute(London)
Page 10 of 18
REC
OCREB #
Sponsor
Study ID
PI
Aurora de
Borja
10-053
NCIC Clinical Trials Group
(NCIC CTG)
IND.198
Mates, Mihaela
Aurora de
Borja
10-055
NCIC Clinical Trials
Group (NCIC CTG)
IND.195
Sridhar (UHN),
Srikala S.
Aurora de
Borja
10-055
NCIC Clinical Trials Group
(NCIC CTG)
IND.195
Sridhar (UHN),
Srikala S.
Cindy
Sandel
11-023
Ontario Clinical
Oncology Group(OCOG)
OCOG-2011BRACHY
Wright, James R.
Cindy
Sandel
11-023
Ontario Clinical Oncology
Group(OCOG)
OCOG-2011BRACHY
Cindy
Sandel
11-023
Ontario Clinical Oncology
Group(OCOG)
Cindy
Sandel
11-023
Cindy
Sandel
Centre
Contact
Application
Type
Expiry Date
Carrie Lindsay
Centre
14-May-15
Ida Lee
Provincial
26-May-15
Ida Lee
Centre
26-May-15
Centre
Kingston General
Hospital
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Yvonne
Kinrade
Provincial
09-May-15
Yu, Edward
Hamilton Health
Sciences
Lawson Health
Research
Institute(London)
Deb Lewis
Centre
09-May-15
OCOG-2011BRACHY
Pan, Ming
Windsor Regional
Hospital
Patricia
Dupuis
Centre
09-May-15
Ontario Clinical Oncology
Group(OCOG)
OCOG-2011BRACHY
Falkson, Conrad B.
Kristina Kulik
Centre
09-May-15
11-023
Ontario Clinical Oncology
Group(OCOG)
OCOG-2011BRACHY
Elantholiparamesw
aran, Saibishkumar
Kingston General
Hospital
UHN-Princess
Margaret Cancer
Centre
Anna Malik
Centre
09-May-15
Cindy
Sandel
11-023
Ontario Clinical Oncology
Group(OCOG)
OCOG-2011BRACHY
Rachakonda ,
Ramana
Grand River
Hospital
Carol
Ballantyne
Centre
09-May-15
Cindy
Sandel
11-023
Ontario Clinical Oncology
Group(OCOG)
OCOG-2011BRACHY
Wright, James R.
Yvonne
Kinrade
Centre
09-May-15
Aurora de
Borja
11-024
Merck Canada Inc.
MK-1775-004
Oza, Amit M.
Hamilton Health
Sciences
UHN-Princess
Margaret Cancer
Centre
Karen Chang
Provincial
09-May-15
Aurora de
Borja
11-024
Merck Canada Inc.
MK-1775-004
Hirte, Holger (Hal)
W.
Aurora de
Borja
11-024
Merck Canada Inc.
MK-1775-004
Aurora de
Borja
11-024
Merck Canada Inc.
MK-1775-004
Teleconference 2015-Apr-17
Yvonne
Kinrade
Centre
09-May-15
Oza, Amit M.
Hamilton Health
Sciences
UHN-Princess
Margaret Cancer
Centre
Karen Chang
Centre
09-May-15
Weberpals,
Johanne
The Ottawa
Hospital
Femina Kanji
Centre
09-May-15
Page 11 of 18
Centre
Contact
Application
Type
Expiry Date
Mary Beth
Husson
Centre
09-May-15
Karen Chang
Provincial
09-May-15
Karen Chang
Centre
09-May-15
Sunnybrook Health
Sciences Centre
Adam Lam
Centre
09-May-15
Hamm, Caroline
Windsor Regional
Hospital
Patricia
Dupuis
Provincial
09-May-15
CAMN107E24
01
Leber, Brian F.
Hamilton Health
Sciences
Yvonne
Kinrade
Centre
09-May-15
CAMN107E24
01
Kuruvilla, Philip
William Osler
Health Centre
Johnson
Dartey
Centre
09-May-15
CAMN107E24
01
Hamm, Caroline
Patricia
Dupuis
Centre
09-May-15
CAMN107E24
01
Xenocostas,
Anargyros
Maisam
Abouzeenni
Centre
09-May-15
CAMN107E24
01
Nay , Derek
Christine Di
Marco
Centre
09-May-15
CSOM230I220
1
Krzyzanowska,
Monika
Jayalakshmi
Ramanna
Provincial
26-May-15
CSOM230I220
1
Krzyzanowska,
Monika
Windsor Regional
Hospital
Lawson Health
Research
Institute(London)
Royal Victoria
Regional Health
Centre
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Jayalakshmi
Ramanna
Centre
26-May-15
IND.205
Hotte, Sébastien J.
Hamilton Health
Sciences
Yvonne
Kinrade
Provincial
09-May-15
REC
OCREB #
Sponsor
Study ID
PI
Aurora de
Borja
11-024
MK-1775-004
Welch, Stephen
Kathie
Zeman
11-025
OTSUKA 28711-201
Moore, Malcolm J.
Kathie
Zeman
11-025
OTSUKA 28711-201
Moore, Malcolm J.
Kathie
Zeman
11-025
OTSUKA 28711-201
Ko, Yoo-Joung
(Yooj)
Aurora de
Borja
11-027
CAMN107E24
01
Aurora de
Borja
11-027
Aurora de
Borja
11-027
Aurora de
Borja
11-027
Aurora de
Borja
11-027
Aurora de
Borja
11-027
Aurora de
Borja
11-029
Aurora de
Borja
11-029
Merck Canada Inc.
Otsuka Pharmaceutical
Development &
Commercialization Inc.
Otsuka Pharmaceutical
Development &
Commercialization Inc.
Otsuka Pharmaceutical
Development &
Commercialization Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Centre
Lawson Health
Research
Institute(London)
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Cindy
Sandel
11-035
NCIC Clinical Trials
Group (NCIC CTG)
Teleconference 2015-Apr-17
Page 12 of 18
Centre
Contact
Application
Type
Expiry Date
Mary Beth
Husson
Centre
09-May-15
Nanthini
Tharahan
Centre
09-May-15
Hamilton Health
Sciences
Yvonne
Kinrade
Centre
09-May-15
Gregg, Richard W.
Kingston General
Hospital
Carrie Lindsay
Centre
09-May-15
E7389-G000398
Verma, Shailendra
The Ottawa
Hospital
Amy
Henderson
Provincial
09-May-15
Eisai Inc.
E7389-G000398
Warner, Ellen
Sunnybrook Health
Sciences Centre
Jeffrey Pham
Centre
09-May-15
11-036
Eisai Inc.
E7389-G000398
Brezden-Masley,
Christine
St. Michael's
Hospital
Aziz Jiwajee
Centre
09-May-15
Aurora de
Borja
11-036
Eisai Inc.
E7389-G000398
Verma, Shailendra
The Ottawa
Hospital
Amy
Henderson
Centre
09-May-15
Kathie
Zeman
12-020
GlaxoSmithKline
MEK116513
Song, Xinni
The Ottawa
Hospital
Lisa Turriff
Provincial
09-May-15
Kathie
Zeman
12-020
GlaxoSmithKline
MEK116513
Petrella, Teresa
Marie
Sunnybrook Health
Sciences Centre
Carolyn Lim
Centre
09-May-15
Kathie
Zeman
12-020
GlaxoSmithKline
MEK116513
Song, Xinni
The Ottawa
Hospital
Lisa Turriff
Centre
09-May-15
Kathie
Zeman
12-020
MEK116513
Baetz, Tara
Kingston General
Hospital
Carrie Lindsay
Centre
09-May-15
Kathie
Zeman
12-021
CP20-0903
Eisen, Andrea
The Ottawa
Hospital
Jeffrey Pham
Provincial
09-May-15
Kathie
Zeman
12-021
GlaxoSmithKline
ImClone Systems
(subsidiary of Eli Lilly
and Company)
ImClone Systems
(subsidiary of Eli Lilly and
Company)
CP20-0903
Eisen, Andrea
Sunnybrook Health
Sciences Centre
Jeffrey Pham
Centre
09-May-15
REC
OCREB #
Sponsor
Study ID
PI
Cindy
Sandel
11-035
NCIC Clinical Trials Group
(NCIC CTG)
IND.205
Winquist, Eric W.
Cindy
Sandel
11-035
NCIC Clinical Trials Group
(NCIC CTG)
IND.205
Joshua, Anthony
Centre
Lawson Health
Research
Institute(London)
UHN-Princess
Margaret Cancer
Centre
Cindy
Sandel
11-035
NCIC Clinical Trials Group
(NCIC CTG)
IND.205
Hotte, Sébastien J.
Cindy
Sandel
11-035
NCIC Clinical Trials Group
(NCIC CTG)
IND.205
Aurora de
Borja
11-036
Eisai Inc.
Aurora de
Borja
11-036
Aurora de
Borja
Teleconference 2015-Apr-17
Page 13 of 18
Centre
Contact
Application
Type
Expiry Date
The Ottawa
Hospital
UHN-Princess
Margaret Cancer
Centre
Amy
Henderson
Provincial
09-May-15
Sujata
Pokhrel
Centre
09-May-15
Amy
Henderson
Centre
09-May-15
Bedard, Philippe
The Ottawa
Hospital
UHN-Princess
Margaret Cancer
Centre
Gayathri
Baranage
Provincial
09-May-15
CBKM120F230
2
Chouinard, Edmond
E.
Cambridge
Memorial Hospital
Stephanie
Evans
Centre
09-May-15
CBKM120F230
2
Trudeau, Maureen
E.
Sunnybrook Health
Sciences Centre
Jeffrey Pham
Centre
09-May-15
CBKM120F230
2
Rahim, Yasmin H.
Southlake Regional
Health Centre
Priyanka
Khandelwal
Centre
09-May-15
CBKM120F230
2
Clemons, Mark J.
Amy
Henderson
Centre
09-May-15
CBKM120F230
2
Bedard, Philippe
Gayathri
Baranage
Centre
09-May-15
CBKM120F230
2
Vandenberg,
Theodore A.
The Ottawa
Hospital
UHN-Princess
Margaret Cancer
Centre
Lawson Health
Research
Institute(London)
Mary Beth
Husson
Centre
09-May-15
Hoffmann-La Roche
Limited (Canada)
BO27952
Shao, Richard
Heng-Fu
William Osler
Health Centre
Christine
Stewart
Provincial
09-May-15
12-024
Hoffmann-La Roche
Limited (Canada)
BO27952
Shao, Richard
Heng-Fu
Toronto East
General Hospital
Christine
Stewart
Centre
09-May-15
Aurora de
Borja
12-024
Hoffmann-La Roche
Limited (Canada)
BO27952
Brezden-Masley,
Christine
St. Michael's
Hospital
Aziz Jiwajee
Centre
09-May-15
Kathie
Zeman
12-025
Agensys Inc.
2008002
Ko, Yoo-Joung
(Yooj)
Sunnybrook Health
Sciences Centre
Adam Lam
Provincial
09-May-15
REC
OCREB #
Sponsor
Study ID
PI
Kathie
Zeman
12-022
NCIC Clinical Trials
Group (NCIC CTG)
IND.208
Jonker, Derek J.
Kathie
Zeman
12-022
NCIC Clinical Trials Group
(NCIC CTG)
IND.208
Chen, Eric (Xueyu)
Kathie
Zeman
12-022
IND.208
Jonker, Derek J.
Cindy
Sandel
12-023
CBKM120F23
02
Cindy
Sandel
12-023
Cindy
Sandel
12-023
Cindy
Sandel
12-023
Cindy
Sandel
12-023
Cindy
Sandel
12-023
Cindy
Sandel
12-023
NCIC Clinical Trials Group
(NCIC CTG)
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Novartis
Pharmaceuticals Canada
Inc.
Aurora de
Borja
12-024
Aurora de
Borja
Teleconference 2015-Apr-17
Centre
Page 14 of 18
Centre
Contact
Application
Type
Expiry Date
Adam Lam
Centre
09-May-15
Kelly Brooks
Provincial
09-May-15
Hamilton Health
Sciences
Yvonne
Kinrade
Provincial
09-May-15
Ko, Yoo-Joung
(Yooj)
Sunnybrook Health
Sciences Centre
Adam Lam
Centre
09-May-15
EMR200592001
McWhirter, Elaine
Hamilton Health
Sciences
Yvonne
Kinrade
Centre
09-May-15
Merck KGaA US Division
(EMD Serono Inc.)
EMR200592001
Shim, Katharine
Edeliza
Mendoza
Centre
09-May-15
13-027
Bristol-Myers Squibb
Canada
CA209067
Hogg, David
Avneet
Grewal
Provincial
09-May-15
Kathie
Zeman
13-027
Bristol-Myers Squibb
Canada
CA209067
Hogg, David
Kathie
Zeman
13-027
Bristol-Myers Squibb
Canada
CA209067
Kathie
Zeman
13-027
Bristol-Myers Squibb
Canada
Kathie
Zeman
13-028
Kathie
Zeman
REC
OCREB #
Sponsor
Study ID
PI
Centre
Kathie
Zeman
12-025
Agensys Inc.
2008002
Ko, Yoo-Joung
(Yooj)
Cindy
Sandel
12-027
Incyte Corporation
INCB 24360210
Oza, Amit M.
Sunnybrook Health
Sciences Centre
UHN-Princess
Margaret Cancer
Centre
Kathie
Zeman
13-026
Merck KGaA US Division
(EMD Serono Inc.)
EMR200592001
McWhirter, Elaine
Kathie
Zeman
13-026
Merck KGaA US Division
(EMD Serono Inc.)
EMR200592001
Kathie
Zeman
13-026
Merck KGaA US Division
(EMD Serono Inc.)
Kathie
Zeman
13-026
Kathie
Zeman
Avneet
Grewal
Centre
09-May-15
Ernst, Scott
Lakeridge Health
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
Lawson Health
Research
Institute(London)
Mary Beth
Husson
Centre
09-May-15
CA209067
Song, Xinni
The Ottawa
Hospital
Lisa Turriff
Centre
09-May-15
NCIC Clinical Trials
Group (NCIC CTG)
CRC.7
Auer, Rebecca Ann
Amy
Henderson
Provincial
09-May-15
13-028
NCIC Clinical Trials Group
(NCIC CTG)
CRC.7
Welch, Stephen
The Ottawa
Hospital
Lawson Health
Research
Institute(London)
Mary Beth
Husson
Centre
09-May-15
Kathie
Zeman
13-028
NCIC Clinical Trials Group
(NCIC CTG)
CRC.7
Auer, Rebecca Ann
The Ottawa
Hospital
Amy
Henderson
Centre
09-May-15
Kathie
Zeman
13-028
NCIC Clinical Trials Group
(NCIC CTG)
CRC.7
Findlay, Brian
Peter
Niagara Health
System
Linda Illes
Centre
09-May-15
Teleconference 2015-Apr-17
Page 15 of 18
REC
OCREB #
Sponsor
Study ID
PI
Kathie
Zeman
13-029
NCIC Clinical Trials
Group (NCIC CTG)
LY.15
Crump, Michael
Kathie
Zeman
13-029
NCIC Clinical Trials Group
(NCIC CTG)
LY.15
Cheung ,
Matthew
Kathie
Zeman
13-029
NCIC Clinical Trials Group
(NCIC CTG)
LY.15
Crump, Michael
Aurora de
Borja
13-031
University Health
Network(sponsor)
MAST_01
Fleshner, Neil
Aurora de
Borja
13-031
University Health
Network(sponsor)
MAST_01
Shayegan, Bobby
Aurora de
Borja
13-031
University Health
Network(sponsor)
MAST_01
Fleshner, Neil
Aurora de
Borja
13-031
University Health
Network(sponsor)
MAST_01
Breau, Rodney
Aurora de
Borja
13-031
University Health
Network(sponsor)
MAST_01
Izawa, Jonathan I
Aurora de
Borja
13-031
MAST_01
Leveridge, Michael
Aurora de
Borja
14-015
PHL-093 / NCI
9568
Oza, Amit M.
Aurora de
Borja
14-015
PHL-093 / NCI
9568
Oza, Amit M.
Aurora de
Borja
14-015
PHL-093 / NCI
9568
Weberpals,
Johanne
Aurora de
Borja
14-015
PHL-093 / NCI
9568
Welch, Stephen
Teleconference 2015-Apr-17
University Health
Network(sponsor)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
Princess Margaret
Hospital Consortium
(PMHC)
Centre
UHN-Princess
Margaret Cancer
Centre
Sunnybrook Health
Sciences Centre
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
St. Joseph's
Healthcare
Hamilton
UHN-Princess
Margaret Cancer
Centre
Centre
Contact
Application
Type
Expiry Date
Nimisha Dave
Provincial
09-May-15
Arlene Mete
Centre
09-May-15
Nimisha Dave
Centre
09-May-15
Sanjna
Kapoor
Provincial
09-May-15
Liz
Sidorkewicz
Centre
09-May-15
Sanjna Kapoor
Centre
09-May-15
Sonya
Cnossen
Centre
09-May-15
Lee-Anne
Fochesato
Centre
09-May-15
Joe Downey
Centre
09-May-15
Karen Chang
Provincial
09-May-15
Karen Chang
Centre
09-May-15
Lisa Turriff
Centre
09-May-15
Mary Beth
Husson
Centre
09-May-15
The Ottawa
Hospital
Lawson Health
Research
Institute(London)
Kingston General
Hospital
UHN-Princess
Margaret Cancer
Centre
UHN-Princess
Margaret Cancer
Centre
The Ottawa
Hospital
Lawson Health
Research
Institute(London)
Page 16 of 18
REC
OCREB #
Sponsor
Study ID
PI
Kathie
Zeman
14-018
AbbVie Corporation
M11-089
Liu, Geoffrey
Kathie
Zeman
14-018
AbbVie Corporation
M11-089
Vincent, Mark
David
Kathie
Zeman
14-018
AbbVie Corporation
M11-089
Ellis, Peter
Kathie
Zeman
14-018
AbbVie Corporation
M11-089
Kathie
Zeman
14-018
AbbVie Corporation
Kathie
Zeman
14-019
Kathie
Zeman
Centre
UHN-Princess
Margaret Cancer
Centre
Lawson Health
Research
Institute(London)
Centre
Contact
Application
Type
Expiry Date
Mary
Tannourji
Provincial
09-May-15
Mary Beth
Husson
Centre
09-May-15
Yvonne
Kinrade
Centre
09-May-15
Liu, Geoffrey
Hamilton Health
Sciences
UHN-Princess
Margaret Cancer
Centre
Nicole PereraLow
Centre
09-May-15
M11-089
Wheatley-Price,
Paul
The Ottawa
Hospital
Amy
Henderson
Centre
09-May-15
Bayer Healthcare
Bayer 15396
Malone, Shawn
The Ottawa
Hospital
Lisa Turriff
Provincial
09-May-15
14-019
Bayer Healthcare
Bayer 15396
Berry, Scott
Sunnybrook Health
Sciences Centre
Jennifer Woo
Centre
09-May-15
Kathie
Zeman
14-019
Bayer Healthcare
Bayer 15396
Malone, Shawn
The Ottawa
Hospital
Femina Kanji
Centre
09-May-15
Kathie
Zeman
14-019
Bayer Healthcare
Bayer 15396
Lukka, Himanshu R.
Hamilton Health
Sciences
Yvonne
Kinrade
Centre
09-May-15
Aurora de
Borja
14-020
Ottawa Hospital
Research Institute
OHSNREB
20130563-01H
Carrier, Marc
The Ottawa
Hospital
Isabel Dao
Provincial
09-May-15
Aurora de
Borja
14-020
Ottawa Hospital
Research Institute
OHSNREB
20130563-01H
Yeo, Erik
UHN-Toronto
General Hospital
Peregrina
Peralta
Centre
09-May-15
Aurora de
Borja
14-020
Ottawa Hospital
Research Institute
OHSNREB
20130563-01H
Carrier, Marc
The Ottawa
Hospital
Isabel Dao
Centre
09-May-15
Aurora de
Borja
14-020
Ottawa Hospital
Research Institute
OHSNREB
20130563-01H
Gross, Peter
Pamela
Stevens
Centre
09-May-15
Aurora de
Borja
14-021
Lawson Health Research
Institute
PET CRPC
Winquist, Eric W.
Mary Beth
Husson
Provincial
09-May-15
Teleconference 2015-Apr-17
Hamilton Health
Sciences
Lawson Health
Research
Institute(London)
Page 17 of 18
Centre
Contact
Application
Type
Expiry Date
Winquist, Eric W.
Centre
Lawson Health
Research
Institute(London)
Mary Beth
Husson
Centre
09-May-15
9785-CL-1121
Trudeau, Maureen
E.
Sunnybrook Health
Sciences Centre
Carolyn Lim
Provincial
09-May-15
Astellas Pharma Global
Development Inc.
9785-CL-1121
Trudeau, Maureen
E.
Sunnybrook Health
Sciences Centre
Carolyn Lim
Centre
09-May-15
14-022
Astellas Pharma Global
Development Inc.
9785-CL-1121
Song, Xinni
The Ottawa
Hospital
Amy
Henderson
Centre
09-May-15
Kathie
Zeman
14-023
Hoffmann-La Roche
Limited (Canada)
BO28984
Cheema, Parneet
Sunnybrook Health
Sciences Centre
Ilda
Carvalhana
Provincial
09-May-15
Kathie
Zeman
14-023
Hoffmann-La Roche
Limited (Canada)
BO28984
Burkes, Ronald
Louis
Mount Sinai
Hospital
Janet Smith
Centre
09-May-15
Kathie
Zeman
14-023
Hoffmann-La Roche
Limited (Canada)
BO28984
Cheema, Parneet
Sunnybrook Health
Sciences Centre
Ilda
Carvalhana
Centre
09-May-15
REC
OCREB #
Sponsor
Study ID
PI
Aurora de
Borja
14-021
Lawson Health Research
Institute
PET CRPC
Kathie
Zeman
14-022
Astellas Pharma Global
Development Inc.
Kathie
Zeman
14-022
Kathie
Zeman
Teleconference 2015-Apr-17
Page 18 of 18